Sarasota’s Roskamp Institute Announces Participation in Multiple Sclerosis Study

Share this postShare on Google+Share on LinkedInShare on FacebookTweet about this on TwitterEmail this to someone

We have just put out a press release announcing the Roskamp Institute’s participation in a multiple sclerosis study.

Here’s a quote from Michael Mullan:

“We are looking for volunteers to participate in this pharmaceutical sponsored research study to assess the effectiveness and safety of the investigational drug fingolimod, used to treat patients with relapsing-remitting MS,” said Dr. Michael Mullan, director of the Roskamp Institute. “We hope by working with Novartis we may be able to provide our patients and their families with another treatment option.”

alzheimers michael mullan